Multiple sources have told HBI that fast-growing German and Swiss ophthalmology group Sanoptis might be looking at a Q2 sale, but HBI understands that is not entirely correct. HBI speaks to Sanoptis CEO Volker Wendel to set the record straight.
The fertility sector is heating up with multiple deals underway. The UK’s largest group by revenue, CARE Fertility, has been bought for £300m by PE firm Nordic Capital; Reuters reports that of $2.2bn are currently being "lined up" for the largest international player, IVI-RMA. And Australia’s largest group, Virtus Health, is being bought by PE firm CapVest for an equity value of A$650m.
Voyage Care, the UK’s largest provider of support for people with learning disabilities by revenue, has been acquired by Wren House Infrastructure, a London-based subsidiary of the Kuwait Investment Authority, Kuwait’s largest sovereign wealth fund. HBI explores the multiple paid, and the thinking behind it.
HBI can exclusively reveal that a substantial UK-based fertility provider looks set to come to market later this year. HBI speaks to sources about possible pricing and buyers.
European imaging and cancer treatment provider Affidea is for sale according to multiple sources. HBI chats to an operator source to find about more about the sale and to speculate on price and purchasers.
HBI has been told that Paris based private equity firm PAI Partners and Ontario Teachers' Pension Plan Board have agreed to acquire Germany based ophthalmology network Veonet from Nordic Capital.
Two more dentistry platforms have been grabbed by two different private equity firms. NHS focused UK dental group Rodericks Dental has sold, HBI hears from multiple sources, and so has German-based KonfiDents. We name the buyers, the multiple, and consider why this development might shake up a stagnating market.
HBI understands that Montagu, owners of Artemis Augenkliniken which is Germany’s second-largest ophthalmology chain by revenue, is in bilateral talks to sell. HBI names the potential buyer, and also has a delve into the ongoing sale - and current finances - of Veonet Group.
"This is the strongest M&A market I can remember," Hedley Goldberg, managing director at Rothschild & Co told hundreds of attendees at HBI 2021 as he talked about the IPO landscape and how post-COVID M&A is shaping up.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.